AstraZeneca gins up $815M in rights deal for Nexium, Vimovo

30th October 2018 Uncategorised 0

AstraZeneca has suffered from significant patent losses in recent years and has looked to asset sales as it refocuses. In its latest deal, the company sold certain rights to Vimovo and Nexium to Gr√ľnenthal.

More: AstraZeneca gins up 5M in rights deal for Nexium, Vimovo
Source: fierce